Literature DB >> 22539000

Characteristics of Lactobacillus and Gardnerella vaginalis from women with or without bacterial vaginosis and their relationships in gnotobiotic mice.

G S Teixeira1, F P Carvalho1, R M E Arantes2, A C Nunes3, J L S Moreira3, M Mendonça4, R B Almeida4, L M Farias1, M A R Carvalho1, J R Nicoli1.   

Abstract

The objectives of the present study were to evaluate in vitro the production of antagonistic compounds against Gardnerella vaginalis by Lactobacillus strains isolated from women with or without bacterial vaginosis (BV), and to select one of the better Lactobacillus producers of such a substance to be tested in vivo using a gnotobiotic animal model challenged with one of the more sensitive G. vaginalis isolates. A total of 24 isolates from women with and without BV were identified as G. vaginalis. A higher frequency (P<0.05) of this bacterium was observed in women with BV (56.7%) when compared to healthy women (17.6%). A total of 86 strains of Lactobacillus were obtained from healthy women and women with BV. Lactobacillus strains were more frequently present (P<0.05) in healthy women (97.5%) than in women with BV (76.7%). Lactobacillus crispatus was the predominating strain in both healthy women and women with BV. Lactobacillus jensenii, Lactobacillus johnsonii, Lactobacillus gasseri and Lactobacillus vaginalis were isolated with an intermediate frequency in the two groups. In vitro antagonism assays were performed using as indicators 17 reference strains and the G. vaginalis strains isolated from women with BV and from healthy women. Lactobacillus isolated from healthy women showed the higher antagonistic activity against all the indicator strains when compared with isolates from women with BV. Concerning the indicator strains, G. vaginalis found in women with BV was more resistant to the antagonism, particularly when Lactobacillus isolates from women with BV were used as producer strains. A high vaginal population level of G. vaginalis was obtained by intravaginal inoculation of germ-free mice, and this colonization was accompanied by vaginal histopathological lesions. A tenfold decrease in vaginal population level of G. vaginalis and a reduction of histological lesions were observed when the pathogenic challenge was performed in mice previously monoassociated with an L. johnsonii strain. Concluding, results of the present study suggest that progression of G. vaginalis-associated BV depends in part on a simultaneous presence of Lactobacillus populations with a low antagonistic capacity and of a G. vaginalis strain with a high resistance to this antagonism. The results could also explain why G. vaginalis is frequently found in the vaginal ecosystem of healthy women.

Entities:  

Mesh:

Year:  2012        PMID: 22539000     DOI: 10.1099/jmm.0.041962-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  15 in total

1.  The Vaginal Microbiome: Current Understanding and Future Directions.

Authors:  David H Martin; Jeanne M Marrazzo
Journal:  J Infect Dis       Date:  2016-08-15       Impact factor: 5.226

Review 2.  New Systems for Studying Intercellular Interactions in Bacterial Vaginosis.

Authors:  Melissa M Herbst-Kralovetz; Richard B Pyles; Adam J Ratner; Laura K Sycuro; Caroline Mitchell
Journal:  J Infect Dis       Date:  2016-08-15       Impact factor: 5.226

3.  Comparison of Lactobacillus crispatus isolates from Lactobacillus-dominated vaginal microbiomes with isolates from microbiomes containing bacterial vaginosis-associated bacteria.

Authors:  Abdallah A Abdelmaksoud; Vishal N Koparde; Nihar U Sheth; Myrna G Serrano; Abigail L Glascock; Jennifer M Fettweis; Jerome F Strauss; Gregory A Buck; Kimberly K Jefferson
Journal:  Microbiology       Date:  2016-01-08       Impact factor: 2.777

4.  Penile Microbiota and Female Partner Bacterial Vaginosis in Rakai, Uganda.

Authors:  Cindy M Liu; Bruce A Hungate; Aaron A R Tobian; Jacques Ravel; Jessica L Prodger; David Serwadda; Godfrey Kigozi; Ronald M Galiwango; Fred Nalugoda; Paul Keim; Maria J Wawer; Lance B Price; Ronald H Gray
Journal:  MBio       Date:  2015-06-16       Impact factor: 7.867

5.  Biological and physicochemical properties of biosurfactants produced by Lactobacillus jensenii P6A and Lactobacillus gasseri P65.

Authors:  I M C Morais; A L Cordeiro; G S Teixeira; V S Domingues; R M D Nardi; A S Monteiro; R J Alves; E P Siqueira; V L Santos
Journal:  Microb Cell Fact       Date:  2017-09-19       Impact factor: 5.328

Review 6.  The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human.

Authors:  Anthony P Corfield
Journal:  Microorganisms       Date:  2018-08-02

7.  Clinical features of bacterial vaginosis in a murine model of vaginal infection with Gardnerella vaginalis.

Authors:  Nicole M Gilbert; Warren G Lewis; Amanda L Lewis
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

8.  Comparative genomics of Lactobacillus crispatus suggests novel mechanisms for the competitive exclusion of Gardnerella vaginalis.

Authors:  Teija Ojala; Matti Kankainen; Joana Castro; Nuno Cerca; Sanna Edelman; Benita Westerlund-Wikström; Lars Paulin; Liisa Holm; Petri Auvinen
Journal:  BMC Genomics       Date:  2014-12-05       Impact factor: 3.969

9.  Lactobacilli inactivate Chlamydia trachomatis through lactic acid but not H2O2.

Authors:  Zheng Gong; Yesmin Luna; Ping Yu; Huizhou Fan
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

10.  High-resolution microbiome profiling uncovers Fusobacterium nucleatum, Lactobacillus gasseri/johnsonii, and Lactobacillus vaginalis associated to oral and oropharyngeal cancer in saliva from HPV positive and HPV negative patients treated with surgery and chemo-radiation.

Authors:  Rafael Guerrero-Preston; James Robert White; Filipa Godoy-Vitorino; Arnold Rodríguez-Hilario; Kelvin Navarro; Herminio González; Christina Michailidi; Anne Jedlicka; Sierra Canapp; Jessica Bondy; Amanda Dziedzic; Barbara Mora-Lagos; Gustavo Rivera-Alvarez; Carmen Ili-Gangas; Priscilla Brebi-Mieville; William Westra; Wayne Koch; Hyunseok Kang; Luigi Marchionni; Young Kim; David Sidransky
Journal:  Oncotarget       Date:  2017-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.